Skip to main content
Fig. 7 | BMC Cancer

Fig. 7

From: Hypermethylation of CDKN2A exon 2 in tumor, tumor-adjacent and tumor-distant tissues from breast cancer patients

Fig. 7

Frequency distribution of promoters with a methylation status ≥ 5% in patients and healthy controls. Frequency refers to tumor, tumor-adjacent and tumor-distant tissues from 16 breast cancer patients and normal breast tissues from four healthy controls. The promoters of the following genes were included: APC, BRCA1, CDKN2A, ESR1, ESR2, HER2/neu, CCND2, DAPK1, GSTP1, HIN-1, MGMT, RASSF1A, ABCB1 and ABCG2. Due to incomplete data sets, promoters of PTEN and ABCC1 and breast cancer patients 1 and 18 were excluded

Back to article page